Literature DB >> 16840353

Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus.

Brian J Willett1, Elizabeth L McMonagle, Francesca Bonci, Mauro Pistello, Margaret J Hosie.   

Abstract

The feline homologue of CD134 is the primary binding receptor for feline immunodeficiency virus (FIV), targeting the virus preferentially to activated CD4+ helper T cells. However, strains of FIV differ in utilization of CD134; the prototypic strain PPR requires a minimal determinant in the first cysteine-rich domain (CRD1) of feline CD134 to confer near-optimal receptor function, while strains such as GL8 require additional determinants in the CD134 CRD2. We map this determinant to a loop in CRD2 governing the interaction between the receptor and its ligand; the amino acid substitutions S78N-S79Y-K80E restored full viral receptor activity to the CDR2 of human CD134 in the context of feline CD134, with tyrosine-79 appearing to be the critical residue for restoration of receptor function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840353      PMCID: PMC1563730          DOI: 10.1128/JVI.00722-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

Review 1.  The molecular architecture of the TNF superfamily.

Authors:  Jean-Luc Bodmer; Pascal Schneider; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

2.  Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates.

Authors:  K Tokunaga; M L Greenberg; M A Morse; R I Cumming; H K Lyerly; B R Cullen
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Common mechanism of infection by lentiviruses.

Authors:  B J Willett; M J Hosie; J C Neil; J D Turner; J A Hoxie
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

4.  LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.

Authors:  D N Mauri; R Ebner; R I Montgomery; K D Kochel; T C Cheung; G L Yu; S Ruben; M Murphy; R J Eisenberg; G H Cohen; P G Spear; C F Ware
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

5.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

Authors:  S G Hymowitz; H W Christinger; G Fuh; M Ultsch; M O'Connell; R F Kelley; A Ashkenazi; A M de Vos
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

6.  Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor.

Authors:  Aymeric de Parseval; Udayan Chatterji; Peiqing Sun; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

7.  Use of CD134 as a primary receptor by the feline immunodeficiency virus.

Authors:  Masayuki Shimojima; Takayuki Miyazawa; Yasuhiro Ikeda; Elizabeth L McMonagle; Hayley Haining; Hiroomi Akashi; Yasuhiro Takeuchi; Margaret J Hosie; Brian J Willett
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

8.  Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

Authors:  D W Banner; A D'Arcy; W Janes; R Gentz; H J Schoenfeld; C Broger; H Loetscher; W Lesslauer
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor.

Authors:  S Mallett; S Fossum; A N Barclay
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus.

Authors:  Brian J Willett; Elizabeth L McMonagle; Susan Ridha; Margaret J Hosie
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more
  18 in total

Review 1.  Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.

Authors:  Alex D Greenwood; Yasuko Ishida; Sean P O'Brien; Alfred L Roca; Maribeth V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2017-12-13       Impact factor: 11.056

2.  Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus.

Authors:  Mauro Pistello; Francesca Bonci; Elisa Zabogli; Francesca Conti; Giulia Freer; Fabrizio Maggi; Mario Stevenson; Mauro Bendinelli
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

3.  Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.

Authors:  Qiong-Ying Hu; Elizabeth Fink; John H Elder
Journal:  Retrovirology (Auckl)       Date:  2012-07-11

4.  Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; Pascal Schneider; Margaret J Hosie
Journal:  Mol Immunol       Date:  2009-02-01       Impact factor: 4.407

Review 5.  Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.

Authors:  Brian J Willett; Margaret J Hosie
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

6.  Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth L McMonagle; Ayman Samman; Margaret J Hosie
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

7.  Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

Authors:  Magnus Sundstrom; Rebecca L White; Aymeric de Parseval; K Jagannadha Sastry; Garrett Morris; Chris K Grant; John H Elder
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

8.  Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; O Brad Spiller; Pascal Schneider; Margaret J Hosie
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

9.  Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth McMonagle; Mariana Varela; Margaret J Hosie
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors.

Authors:  William A McEwan; Elizabeth L McMonagle; Nicola Logan; Rodrigo C Serra; Pieter Kat; Sue Vandewoude; Margaret J Hosie; Brian J Willett
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.